CUTISS AG logo

CUTISS AG

FIRST-IN-CLASS SKIN TISSUE THERAPEUTICS - late clinical stage TECH-BIO company

61 employees · est. 2017 · Schlieren, Switzerland

VS
Kerecis logo

Kerecis

Kerecis is pioneering the use of fish skin and fatty-acids in the cellular therapy and regenerative medicine market.

517 employees · est. 2011 · Iceland

Kerecis is the older company (2017 vs 2011); Kerecis is the larger of the two.

Side-by-Side Comparison

CUTISS AG Kerecis
Founded
2017 2011 older
Headquarters
Schlieren, Switzerland Iceland
Employees
61 517 larger
Industry
Biotechnology, Health Care, Wellness Beauty Health Care, Manufacturing, Medical Devices
Funding Stage
Series C Debt Financing
Total Funding
$109.66M $210.77M
Funding Rounds
9 19
Services
Development of denovoSkin™, Automated Living Skin Production, Scalable Bioengineering Solutions, Clinical Manufacturing Not tracked yet
Target Customers
Burn Patients, Healthcare Providers in Reconstructive Surgery, Aesthetic Surgery Centers, Regenerative Medicine Researchers, Industrial Partners for Bioengineering Not tracked yet
Taxonomy
Skin Tissue Therapy, Personalized Medicine, Bioengineering, TechBio, Automated Manufacturing, Regenerative Medicine, Clinical Trials, Orphan Drug Designation, Burn Treatment, Reconstructive Surgery, Aesthetic Procedures, Scalable Healthcare Solutions, Regulatory Approvals, Skin Graft Technology, Bio-technopark Zurich Regenerative Medicine, Cellular Therapy, Wound Care, Burn Treatment, Surgical Procedures, Dental Applications, Omega-3, Fish-skin Technology, Tissue Regeneration, Startup, Investment, Healthcare Innovation, Biomedical Research
Website
cutiss.swiss kerecis.com
CUTISS AG logo

About CUTISS AG

CUTISS AG, a pioneering force in BIOTECHNOLOGY and HEALTH CARE, is redefining skin surgery with its innovative skin tissue therapeutics. Established in 2017 as a spin-off from the University of Zurich (UZH) and University Children’s Hospital, this Swiss firm is headquartered at the Bio-Technopark in...

Kerecis logo

About Kerecis

Kerecis is a pioneering company in the cellular therapy and regenerative medicine market, using fish skin and fatty acids to revolutionize tissue healing. Founded in 2009 by Fertram Sigurjonsson, the company's patented technologies leverage fatty-acid rich products to enable tissue regeneration, min...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at CUTISS AG and Kerecis — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at CUTISS AG and Kerecis — by email.

Frequently Asked Questions

CUTISS AG — FIRST-IN-CLASS SKIN TISSUE THERAPEUTICS - late clinical stage TECH-BIO company. Kerecis — Kerecis is pioneering the use of fish skin and fatty-acids in the cellular therapy and regenerative medicine market.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
CUTISS AG has raised $109.66M while Kerecis has raised $210.77M.
CUTISS AG and Kerecis operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare CUTISS AG with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy